SCHEMBL10695735

SCHEMBL10695735

NN(CCC[C]=O)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
AOC3 Q16853 2/20 0.36
ADRA2C P18825 1/20 0.34
KCNA3 P22001 1/20 0.32
KCNN4 O15554 1/20 0.32
KCNA5 P22460 1/20 0.32
USP2 O75604 1/20 0.31
HSD17B10 Q99714 1/20 0.31
MEN1 O00255 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
KMT2A Q03164 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
ESR1 P03372 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30
ALDH1A1 P00352 1/20 0.30
ALOX15 P16050 1/20 0.30
TP53 P04637 1/20 0.30
HTT P42858 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9717165 0.81 AOC3 (0.45) AOC3ADRA2CCYP3A4CYP2C9CYP2C19
SCHEMBL10695564 0.80 KCNA3 (0.42) KCNA3HSD17B10MEN1KMT2ASMN1; SMN2
SCHEMBL10697193 0.77 CA12 (0.42) AOC3USP2MEN1KMT2AHTT
SCHEMBL9717180 0.76 AOC3 (0.43) AOC3MEN1CYP3A4CYP2C9CYP2C19
SCHEMBL10765887 0.74 MTNR1A (0.41) KCNA3
SCHEMBL449304 0.74 ESR1 (0.46) AOC3HSD17B10MEN1KMT2ASMN1; SMN2
SCHEMBL6488567 0.74 AOC3 (0.64) AOC3
SCHEMBL6485606 0.73 HDAC3 (0.47) ADRA2CSMN1; SMN2NPSR1ALDH1A1TP53
SCHEMBL253120 0.72 NPC1 (0.47) AOC3ESR1TP53
SCHEMBL6627229 0.72 USP2 (0.46) KCNA3KCNN4KCNA5USP2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0252482-A2 7-Acyloxy-6-aminoacyloxypolyoxylabdanes, process for their preparation and their use as medicine HOECHST AKTIENGESELLSCHAFT (DE) 1988-01-13 EP disclosed
EP-0217372-A2 Polyoxygenated labdane derivatives, process for their preparation and their use as medicaments HOECHST AKTIENGESELLSCHAFT (DE) 1987-04-08 EP disclosed